Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,214 | 0 | 0 | N/A | 0 |
| Other current assets | 43 | 0 | 0 | 0 | 0 |
| TOTAL | $6,257 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| Intangibles | 17 | 0 | 0 | 0 | 0 |
| TOTAL | $17 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $6,274 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 800 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 43 | 0 | 0 | N/A | 0 |
| Other current liabilities | 773 | 0 | 0 | N/A | 0 |
| TOTAL | $1,616 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,616 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,019 | N/A | N/A | N/A | N/A |
| Common Shares | 12 | 0 | 0 | N/A | 0 |
| Retained earnings | -27,926 | 0 | 0 | N/A | 0 |
| TOTAL | $4,658 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $6,274 | $0 | $0 | $0 | $0 |